NASOVAC-S4: India’s First Needle-free and Painless Seasonal Flu Vaccine
0
Billion
Estimated 1 billion cases of influenza occur globally
5%-
0
%
Annual attack rate estimated at 5%-10% in adults and 20%-30% in children
1/5 & 1/
0
Estimated to infect unvaccinated population 1 in 5 children & 1 in 10 adults
Source: WHO
NASOVAC-S4
Introducing NASOVAC-S4, India’s FIRST quadrivalent needle-free influenza (seasonal flu) vaccine. Covers 2 Type A (H1N1 and H3N2) & 2 Type B (Victoria and Yamagata lineage)
Benefits
Quadrivalent vaccine that offers broad immune response over trivalent vaccines
Intranasal vaccination mimics the natu ra 1 route of infection
Suitable for individuals aged 2 and above, including diabetic and hypertension patients
Needle-free vaccine which is non-invasive and painless
Double protection with mucosal and systemic immune response
NASOVAC-S4 Product Details
NASOVAC-S4 is a live attenuated quadrivalent vaccine that protects from four virus strains
Dosage
A single intranasal dose of 0.5 ml, administered as 0.25 ml per nostril
Storage Requirement
Storage Requirements: Store in a refrigerator at 2ºC – 8ºC. Do not freeze
NASOVAC-S4 Administration Method
Administering NASOVAC-S4 is simple and convenient. Follow these easy steps
Enquiry Now
